TEAM (Thiotepa, Etoposide, Cytarabine, Melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation

被引：0
|
作者：
Carella, A. M. [1 ]
Palumbo, G. [2 ]
Greco, M. M. [1 ]
Merla, E. [1 ]
Dell'Olio, M. [1 ]
Pisapia, G. [3 ]
Mazza, P. [3 ]
Ferrara, F. [4 ]
Musto, P. [5 ]
Rana, A. [6 ]
Guarini, A. [6 ]
Di Tonno, P. [7 ]
Pastore, D. [8 ]
D'Elia, M. [8 ]
Specchia, G. [8 ]
Capalbo, S. [2 ]
Cascavilla, N. [1 ]
机构：
[1] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[2] United Hosp, Foggia, Italy
[3] Hosp G Moscati, Taranto, Italy
[4] Hosp Cardarelli, Naples, Italy
[5] CROB, Rionero In Vulture, Italy
[6] IRCCS Canc Inst, Bari, Italy
[7] Hosp Di Venere, Bari, Italy
[8] Univ Hematol, Bari, Italy
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [41] A novel conditioning regimen or thiotepa, melphalan, and cyclophosphamide for autologous stem cell transplantation (ASCT) in chemosensitive multiple myeloma.
    Venigalla, M
    Azar, D
    Becker, P
    Emmons, R
    Westervelt, P
    Hsieh, CC
    Qin, L
    Ballen, K
    BLOOD, 2002, 100 (11) : 436A - 436A
  • [42] Comparison of Beam and Team as Conditioning Regimen for Lymphoma Patients undergoing Autologous Stem Cell Transplantation
    Atesoglu, Elif Birtas
    Deveci, Burak
    Dora, Imran
    Eren, Cigdem
    Celik, Suat
    Kusdemir, Gokhan
    Bayrak, Esra
    Karadogan, Ihsan
    Gulbas, Zafer
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 302 - 302
  • [43] Maximum Tolerated Dose of Lomustine in Combination with Etoposide, Cytarabine and Melphalan in a Short Conditioning Regimen in the Transplantation of Hematopoietic Stem Cells in Patients with Lymphoma
    Hallack Neto, Abrahao Elias, Sr.
    Santos, Kelli Borges
    Atalla, Angelo
    Ruiz, Milton
    Costa, Luciano J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S111 - S111
  • [44] BUSULPHAN-MELPHALAN VERSUS CARBOPLATIN-ETOPOSIDE-MELPHALAN CONDITIONING REGIMEN IN CHILDREN WITH NEUROBLASTOMA UNDERWENT AUTOLOGOUS STEM CELL TRANSPLANTATION
    Atas, E.
    Kesik, V.
    Babacan, O.
    Korkmazer, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S206 - S206
  • [45] TECAM (THIOTEPA, ETOPOSIDE, CYCLOPHOSPHAMIDE, ARA-C AND MELPHALAN) AS CONDITONING REGIMEN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH NON-HODGKIN AND HODGKIN LYMPHOMA
    Patir, P.
    Duran, M.
    Koseoglu, F.
    Uysal, A.
    Sahin, F.
    Tobu, M.
    Saydam, G.
    Vural, F.
    LEUKEMIA RESEARCH, 2016, 49 : S37 - S38
  • [46] LOMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN (LEAM) PROTOCOL AS CONDITIONING REGIMEN BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH LYMPHOMAS: A SINGLE CENTER EXPERIENCE
    Prka, Zeljko
    Vuk, Anamarija Vrkljan
    Cicic, David
    Soric, Ena
    Mitrovic, Zdravko
    Lucijanic, Marko
    Cikara, Marija Ivic
    Jonjic, Zeljko
    Pirsic, Mario
    Pejsa, Vlatko
    Jaksic, Ozren
    BONE MARROW TRANSPLANTATION, 2024, 59 : 267 - 268
  • [47] Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas
    Jo, Jae-Cheol
    Kim, Jin-Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Im, Seong Nam
    Lee, Sang-Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Bae, Seong Hwa
    Lee, Yoo Jin
    Choi, Yunsuk
    Lee, Won-Sik
    ANNALS OF HEMATOLOGY, 2021, 100 (01) : 189 - 196
  • [48] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma
    Di Ianni, Mauro
    Ballanti, Stelvio
    Iodice, Giuseppe
    Reale, Antonia
    Falzetti, Franca
    Minelli, Olivia
    Serio, Gabriella
    Martelli, Massimo F.
    Dammacco, Franco
    Vacca, Angelo
    Ria, Roberto
    HEMATOLOGY, 2012, 17 (01) : 23 - 27
  • [49] Single-center retrospective study assessing the efficacy and safety of BeEAM (bendamustine, etoposide, cytarabine, melphalan) as conditioning regimen for autologous hematopoietic stem cell transplantation
    Plante, Marie-Elaine
    Feng, Xue
    Boudreault, Jean-Samuel
    LEUKEMIA & LYMPHOMA, 2023, 64 (07) : 1234 - 1242
  • [50] Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas
    Jae-Cheol Jo
    Jin-Seok Kim
    Je-Hwan Lee
    Jung-Hee Lee
    Seong Nam Im
    Sang-Min Lee
    Sung-Soo Yoon
    In-Ho Kim
    Seong Hwa Bae
    Yoo Jin Lee
    Yunsuk Choi
    Won-Sik Lee
    Annals of Hematology, 2021, 100 : 189 - 196
12345